
### [MONDO:0017410](http://purl.obolibrary.org/obo/MONDO_0017410)
**Label:** porencephaly

**Subclasses:** [MONDO:0020496](http://purl.obolibrary.org/obo/MONDO_0020496) (familial porencephaly), 

**Corr. equiv. classes:** [OMIM:614483](http://purl.obolibrary.org/obo/OMIM_614483), [Orphanet:99810](http://www.orpha.net/ORDO/Orphanet_99810), [OMIM:175780](http://purl.obolibrary.org/obo/OMIM_175780), 

**Class expressions from DL-Learner:**

- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0100659](http://purl.obolibrary.org/obo/HP_0100659) (Abnormality of the cerebral vasculature) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0030182](http://purl.obolibrary.org/obo/HP_0030182) (Tetraplegia/tetraparesis) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 66.67%
- [HP:0007209](http://purl.obolibrary.org/obo/HP_0007209) (Facial paralysis) and [HP:0011004](http://purl.obolibrary.org/obo/HP_0011004) (Abnormal systemic arterial morphology) 66.67%


